{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T03:40:24Z","timestamp":1730432424969,"version":"3.28.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Theoretically, endocrine fluctuations occurring during infertility treatments, including ovulation induction (OI) and assisted reproductive techniques (ART), could be associated with an increased risk of benign breast diseases (BBDs). To date, no studies have been conducted on this association. Therefore, the present study investigated the association between different types of infertility treatments and BBDs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This case\u2012control study was conducted in Arash Women\u2019s Hospital, Tehran, Iran. The case group included infertile women diagnosed with BBDs without atypia, and the control group included infertile women without breast disease. Breast imaging studies (mammography\/ultrasound) were performed for BBD screening, and the diagnosis was confirmed by histopathological examination. Study variables were collected retrospectively from medical records, hospital databases, and questionnaires.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Finally, 154 infertile women, including 50 cases (BBDs) and 104 controls (no BBDs), were compared. Our data showed that 66% of cases and 61.4% of controls had undergone at least one course of infertility treatment. There was no association between BBD risk and previous infertility treatments (OR\u2009=\u20091.21; 95% CI\u2009=\u20090.59\u20132.46), ART (OR\u2009=\u20091.14; 95% CI\u2009=\u20090.90\u20131.44), or OI cycles (OR\u2009=\u20091.13; 95% CI\u2009=\u20090.98\u20131.32). Stratification by confounding variables did not change these results.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>It seems that there is no association between BBDs in infertile women and the type, duration, or number of prior infertility treatments; however, considering the small sample size of the study, the clinical significance of this finding should not be neglected. Therefore, we consider it essential to carry out more extensive, detailed, and prospective studies to distinguish the association of BBDs with different infertility treatments and medications.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-024-03429-w","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T03:04:29Z","timestamp":1730430269000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Infertility treatments and risk of breast benign diseases: a case\u2012control study"],"prefix":"10.1186","volume":"24","author":[{"given":"Ashraf","family":"Moini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadaf","family":"Alipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Zandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arezoo","family":"Maleki-Hajiagha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ladan","family":"kashani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Shakki katouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam Farid","family":"Mojtahedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Bayani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahboubeh","family":"Abedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"3429_CR1","doi-asserted-by":"crossref","unstructured":"Sangma MMB, Panda K, Dasiah S. A clinico-pathological study on benign breast diseases. J Clin Diagn Res. 2013;7.","DOI":"10.7860\/JCDR\/2012\/5355.2807"},{"key":"3429_CR2","doi-asserted-by":"crossref","unstructured":"El-Wakeel H, Umpleby HC. Systematic review of fibroadenoma as a risk factor for breast cancer. Breast. 2003;12.","DOI":"10.1016\/S0960-9776(03)00123-1"},{"key":"3429_CR3","doi-asserted-by":"crossref","unstructured":"DL WDD. P. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 312:146\u201351.","DOI":"10.1056\/NEJM198501173120303"},{"key":"3429_CR4","doi-asserted-by":"crossref","unstructured":"Figueroa JD, Gierach GL, Duggan MA, Fan S, Pfeiffer RM, Wang Y et al. Risk factors for breast cancer development by tumor characteristics among women with benign breast disease. Breast Cancer Res. 2021;23.","DOI":"10.1186\/s13058-021-01410-1"},{"key":"3429_CR5","doi-asserted-by":"crossref","unstructured":"Kuang K, Wilson SR. A Meta-Analysis of Uncertainty and Information Management in Illness Contexts. J Communication. 2017;67.","DOI":"10.1111\/jcom.12299"},{"key":"3429_CR6","doi-asserted-by":"crossref","unstructured":"Hayes Balmadrid MA, Shelby RA, Wren AA, Miller LS, Yoon SC, Baker JA et al. Anxiety prior to breast biopsy: Relationships with length of time from breast biopsy recommendation to biopsy procedure and psychosocial factors. J Health Psychol. 2017;22.","DOI":"10.1177\/1359105315607828"},{"key":"3429_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/oxfordjournals.aje.a113216","volume":"114","author":"I Soini","year":"1981","unstructured":"Soini I, Aine R, Lauslahti K, Hakama M. Independent risk factors of benign and malignant breast lesions. Am J Epidemiol. 1981;114:507\u201314.","journal-title":"Am J Epidemiol"},{"key":"3429_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa044383","volume":"353","author":"LC Hartmann","year":"2005","unstructured":"Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, et al. Benign Breast Disease and the Risk of Breast Cancer. N Engl J Med. 2005;353:229\u201337.","journal-title":"N Engl J Med"},{"key":"3429_CR9","doi-asserted-by":"crossref","unstructured":"Momenimovahed Z. and HS-BCT, 2019 undefined. Epidemiological characteristics of and risk factors for breast cancer in the world. Taylor & Francis. 2019;11:151\u201364.","DOI":"10.2147\/BCTT.S176070"},{"key":"3429_CR10","unstructured":"Beral V, Bull D, Doll R, Peto R, \u2026 GR-, 2004 undefined. Collaborative group on hormonal factors in breast cancer: breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including. cris.maastrichtuniversity.nl."},{"key":"3429_CR11","doi-asserted-by":"crossref","unstructured":"Zreik T, Mazloom A, Chen Y, \u2026 MV-B cancer research, 2010 undefined. Fertility drugs and the risk of breast cancer: a meta-analysis and review. Springer.","DOI":"10.1007\/s10549-010-1140-4"},{"key":"3429_CR12","doi-asserted-by":"crossref","unstructured":"Beebeejaun Y, Athithan A, Copeland T, \u2026 MK-F and, 2021 undefined. Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: a systematic review and meta-analysis. Elsevier.","DOI":"10.1016\/j.fertnstert.2021.01.044"},{"key":"3429_CR13","unstructured":"Sergentanis T, \u2026 AD-H reproduction, 2014 undefined. IVF and breast cancer: a systematic review and meta-analysis. academic.oup.com."},{"key":"3429_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10549-015-3328-0","volume":"150","author":"A Gennari","year":"2015","unstructured":"Gennari A, Costa M, Puntoni M, Paleari L, De Censi A, Sormani MP, et al. Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies. Breast Cancer Res Treat. 2015;150:405\u201313.","journal-title":"Breast Cancer Res Treat"},{"key":"3429_CR15","doi-asserted-by":"crossref","unstructured":"Farland LV, Wang S, Rich-Edwards JW, Gaskins AJ, Chavarro JE, Wang YX et al. History of infertility and risk of breast cancer: a prospective cohort study. Breast Cancer Res Treat. 2023;199.","DOI":"10.1007\/s10549-023-06907-1"},{"key":"3429_CR16","doi-asserted-by":"crossref","unstructured":"Wang S, Gaskins AJ, Farland LV, Zhang D, Birmann BM, Rich-Edwards JW et al. A prospective cohort study of infertility and cancer incidence. Fertil Steril. 2023;120.","DOI":"10.1016\/j.fertnstert.2023.02.028"},{"key":"3429_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.fertnstert.2019.10.014","volume":"113","author":"A Penzias","year":"2020","unstructured":"Penzias A, Bendikson K, Falcone T, Hansen K, Hill M, Jindal S, et al. Evidence-based treatments for couples with unexplained infertility: a guideline. Fertil Steril. 2020;113:305\u201322.","journal-title":"Fertil Steril"},{"key":"3429_CR18","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1158\/0008-5472.CAN-13-3514","volume":"74","author":"C Catsburg","year":"2014","unstructured":"Catsburg C, Gunter MJ, Chen C, Cote ML, Kabat GC, Nassir R, et al. Insulin, estrogen, inflammatory markers, and risk of benign proliferative breast disease. Cancer Res. 2014;74:3248\u201358.","journal-title":"Cancer Res"},{"key":"3429_CR19","doi-asserted-by":"publisher","first-page":"e2114716","DOI":"10.1001\/jamanetworkopen.2021.14716","volume":"4","author":"A Johansson","year":"2021","unstructured":"Johansson A, Christakou AE, Iftimi A, Eriksson M, Tapia J, Skoog L, et al. Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden. JAMA Netw Open. 2021;4:e2114716\u20132114716.","journal-title":"JAMA Netw Open"},{"key":"3429_CR20","unstructured":"Andarieh M, Delavar M, \u2026 DM-J of C, 2019 undefined. Infertility as a risk factor for breast cancer: Results from a hospital-based case\u2013control study. journals.lww.com."},{"key":"3429_CR21","doi-asserted-by":"crossref","unstructured":"Stentz NC, Koelper N, Barnhart KT, Sammel MD, Senapati S. Infertility and mortality. Am J Obstet Gynecol. 2020;222:251.e1-251.e10.","DOI":"10.1016\/j.ajog.2019.09.007"},{"key":"3429_CR22","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s10654-018-0474-9","volume":"34","author":"FE Lundberg","year":"2019","unstructured":"Lundberg FE, Iliadou AN, Rodriguez-Wallberg K, Gemzell-Danielsson K, Johansson ALV. The risk of breast and gynecological cancer in women with a diagnosis of infertility: a nationwide population-based study. Eur J Epidemiol. 2019;34:499\u2013507.","journal-title":"Eur J Epidemiol"},{"key":"3429_CR23","doi-asserted-by":"crossref","unstructured":"Colditz G. epidemiology BR-A journal of, 2000 undefined. Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses\u2019 Health Study. academic.oup.com.","DOI":"10.1093\/aje\/152.10.950"},{"key":"3429_CR24","doi-asserted-by":"crossref","unstructured":"Goehring C, reviews AM-E. 1997 undefined. Epidemiology of benign breast disease, with special attention to histologic types. doc.rero.ch","DOI":"10.1093\/oxfordjournals.epirev.a017960"},{"key":"3429_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/BF01806008","volume":"6","author":"DY Wang","year":"1985","unstructured":"Wang DY, Fentiman IS. Epidemiology and endocrinology of benign breast disease. Breast Cancer Res Treat. 1985;6:5\u201336.","journal-title":"Breast Cancer Res Treat"},{"key":"3429_CR26","first-page":"639","volume":"70","author":"JR Pasqualini","year":"1997","unstructured":"Pasqualini JR, Cortes-Prieto J, Chetrite G, Talbi M, Ruiz A. Concentrations of estrone, estradiol and their sulfates, and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma. Wiley Online Libr. 1997;70:639\u201343.","journal-title":"Wiley Online Libr"},{"key":"3429_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1210\/jcem-73-1-8","volume":"73","author":"C Malet","year":"1991","unstructured":"Malet C, Gompel A, Yaneva H, Cren H, Fidji N, Mowszowicz I, et al. Estradiol and Progesterone Receptors in Cultured Normal Human Breast Epithelial Cells and Fibroblasts: Immunocytochemical Studies. J Clin Endocrinol Metab. 1991;73:8\u201317.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-024-03429-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-024-03429-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-024-03429-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T03:04:51Z","timestamp":1730430291000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-024-03429-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3429"],"URL":"https:\/\/doi.org\/10.1186\/s12905-024-03429-w","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"assertion":[{"value":"18 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was designed and conducted in accordance with the Declaration of Helsinki, and the study protocol was approved by the research ethics committees of Tehran University of Medical Sciences, Tehran, Iran (ethics approval code: IR.TUMS.MEDICINE.REC.1399.1072).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was obtained from all participants before the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"584"}}